Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ENvue Medical (FEED) EBITDA (2017 - 2025)

Historic EBITDA for ENvue Medical (FEED) over the last 11 years, with Q3 2025 value amounting to $508000.0.

  • ENvue Medical's EBITDA rose 15074.93% to $508000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.4 million, marking a year-over-year decrease of 13822.87%. This contributed to the annual value of -$3.7 million for FY2024, which is 111.7% up from last year.
  • Per ENvue Medical's latest filing, its EBITDA stood at $508000.0 for Q3 2025, which was up 15074.93% from -$4.0 million recorded in Q2 2025.
  • ENvue Medical's EBITDA's 5-year high stood at $508000.0 during Q3 2025, with a 5-year trough of -$4.0 million in Q2 2025.
  • In the last 5 years, ENvue Medical's EBITDA had a median value of -$1.1 million in 2023 and averaged -$1.3 million.
  • Examining YoY changes over the last 5 years, ENvue Medical's EBITDA showed a top increase of 15074.93% in 2025 and a maximum decrease of 47496.38% in 2025.
  • Quarter analysis of 5 years shows ENvue Medical's EBITDA stood at -$2.5 million in 2021, then grew by 17.13% to -$2.1 million in 2022, then skyrocketed by 60.29% to -$826000.0 in 2023, then crashed by 73.85% to -$1.4 million in 2024, then soared by 135.38% to $508000.0 in 2025.
  • Its last three reported values are $508000.0 in Q3 2025, -$4.0 million for Q2 2025, and -$2.5 million during Q1 2025.